The FDA has issued warning letters to several companies selling products with cannabidiol (CBD) and delta-8 tetrahydrocannabinol (delta-8 THC) in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). While the agency has previously sent out warnings to firms selling CBD-related products from 2015 to 2022, it is the first time it has sent…